Precision BioSciences, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    (estimated) €44.75M +64.4% -€36.98M -27.0% -82.6% +1.0 pp €24.51M -22.8% 54.8% -0.62 pp
    (estimated) €27.21M +11.4% -€50.66M +5.4% -186.2% +0.11 pp €31.76M +28.2% 116.7% +0.15 pp
    (estimated) €24.42M +11.4% -€48.05M +51.2% -196.7% -0.52 pp €24.77M +63.1% 101.4% +0.32 pp
    (estimated) €21.92M +135.2% -€31.79M -45.1% -145.0% +4.8 pp €15.19M -138.9% 69.3% +4.9 pp
    (estimated) €9.32M -84.3% -€57.94M -1,036.7% -621.6% -6.3 pp -€39.01M -22.3% -418.5% -3.3 pp
    €59.29M +41.0% €6.19M -111.7% 10.4% +1.4 pp -€50.22M -28.9% -84.7% +0.83 pp
    €42.05M +94.1% -€52.92M -50.1% -125.8% +3.6 pp -€70.63M +92.9% -167.9% +0.011 pp
    €21.66M -78.3% -€106.07M +297.5% -489.7% -4.6 pp -€36.62M +740.3% -169.1% -1.6 pp
    €99.71M +375.7% -€26.68M -71.6% -26.8% +4.2 pp -€4.36M -93.9% -4.4% +3.3 pp
    €20.96M +9.2% -€94.08M +30.9% -448.9% -0.74 pp -€71.08M +77.7% -339.1% -1.3 pp
    €19.19M +104.3% -€71.89M +80.9% -374.6% +0.48 pp -€40.00M +28.6% -208.4% +1.2 pp
    €9.39M +67.8% -€39.73M +118.2% -423.0% -0.98 pp -€31.11M +93.7% -331.2% -0.44 pp
    €5.60M -7.6% -€18.21M +155.8% -325.4% -2.1 pp -€16.06M -119.7% -286.9% -16 pp
    €6.05M -€7.12M -117.6% €81.43M 1,345.0%

    Notifications